Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007)
About Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007)
"Rokotetutkimuskeskus on Tampereen yliopiston lääketieteen ja terveysteknologian tiedekunnan alaisuudessa toimiva erikoisyksikkö. Toteutamme tieteellisesti ja eettisesti korkeatasoisia, kliinisiä rokotetutkimuksia yhdessä rokotevalmistajien kanssa, sekä omia akateemisia tutkimushankkeita. Tavoitteemme on saada käyttöön uusia, entistä turvallisempia ja tehokkaampia rokotteita lapsille, nuorille ja aikuisille. Rokotetutkimuskeskusta johtaa professori Mika Rämet."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007)
During the past decade, Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
2009-04-01
2013-02-01
Completed
817
Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression
2010-11-01
2012-08-01
Completed
356
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
2013-12-01
2016-09-01
Completed
306
Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid Arthritis
2016-11-07
2019-02-13
Completed
259
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007)
According to Clinical.Site data, the most researched conditions in "Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007)" are
"Pneumococcal Infections" (2 trials). Many other conditions were trialed in "Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007)" in a lesser frequency.
Clinical Trials Intervention Types at Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007)
Most popular intervention types in "Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007)" are "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Prevnar 13®" (1 trials), "Prevnar 13™" (1 trials), "V114" (1 trials), "V114 Lot 1" (1 trials) and "V114 Lot 2" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007)
The vast majority of trials in "Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007)" are
2 trials for "All" genders.
Clinical Trials Status at Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007)
Currently, there are NaN active trials in "Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007)".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007), 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".